Showing results (211-220 of 293) with videos related to

Sort By:
Pageof 30
Journal of Acquired Immune Deficiency Syndromes (1999)|June 6, 2002
gp120-Independent infection of CD4(-) epithelial cells and CD4(+) T-cells by HIV-1Yen-Hung Chow, Duan Yu, Jun-Ying Zhang, et al.
Eclinicalmedicine|May 4, 2022
Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohortAdam Hampshire, Doris A Chatfield, Anne Manktelow MPhil, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 12, 2025
Remote cognitive tests predict neurodegenerative biomarkers in the Insight 46 cohortMartina Del Giovane, Valentina Giunchiglia, Ziyuan Cai, et al.
BMJ Open|January 10, 2024
Protocol for the challenge non-typhoidal Salmonella (CHANTS) study: a first-in-human, in-patient, double-blind, randomised, safety and dose-escalation controlled human infection model in the UKChristopher Smith, Emma Smith, Anna Rydlova, et al.
American Journal of Respiratory and Critical Care Medicine|February 13, 2019
Local and Systemic Immunity against Respiratory Syncytial Virus Induced by a Novel Intranasal Vaccine. A Randomized, Double-Blind, Placebo-controlled Clinical TrialStephanie Ascough, Iris Vlachantoni, Mohini Kalyan, et al.
Influenza and Other Respiratory Viruses|November 4, 2024
Inno4Vac Workshop Report Part 1: Controlled Human Influenza Virus Infection Model (CHIVIM) Strain Selection and Immune Assays for CHIVIM Studies, November 2021, MHRA, UKJoanna Waldock, Rebecca J Cox, Christopher Chiu, et al.
Epidemics|September 11, 2022
The role of public involvement in the design of the first SARS-CoV-2 human challenge study during an evolving pandemicMaria Piggin, Emma Smith, Peter Mankone, et al.
Influenza and Other Respiratory Viruses|October 23, 2024
Inno4Vac Workshop Report Part 2: RSV-Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UKJoanna Waldock, Rebecca J Cox, Othmar G Engelhardt, et al.
Wellcome Open Research|March 24, 2022
Public attitudes to a human challenge study with SARS-CoV-2: a mixed-methods studyCaroline Barker, Katharine Collet, Diane Gbesemete, et al.
The Lancet. Microbe|June 12, 2023
Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human studyJie Zhou, Anika Singanayagam, Niluka Goonawardane, et al.
Pageof 30